Haleon (HLN) Non Operating Interest Expenses (2021 - 2023)

Haleon (HLN) posted Non Operating Interest Expenses of -$371.1 million for Q4 2023, down 139.16% on a QoQ basis from -$155.2 million in Q2 2023, and down 300.5% year-over-year from $185.1 million in Q4 2022.

Haleon (HLN) Non Operating Interest Expenses (2021 - 2023) Analysis & Trends

Haleon's Non Operating Interest Expenses history runs 3 years deep, the most recent figure standing at -$371.1 million for Q4 2023.

  • Quarterly Non Operating Interest Expenses fell 300.5% year-over-year to -$371.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$735.1 million (changed N/A YoY) and the FY2024 annual result came in at -$490.9 million, up 1.83% from the prior year.
  • Non Operating Interest Expenses was -$371.1 million for Q4 2023 at Haleon, down from -$155.2 million in the prior quarter.
  • Across five years, Non Operating Interest Expenses topped out at -$18.9 million in Q4 2021 and bottomed at -$371.1 million in Q4 2023.
  • A 3-year average of -$141.9 million and a median of -$106.7 million in 2022 frame the typical range for Non Operating Interest Expenses.
  • Annual changes were most pronounced in 2022 — Non Operating Interest Expenses tumbled 391.0% — and 2023, when it tumbled 300.5%.
  • Haleon's Non Operating Interest Expenses stood at -$18.9 million in 2021, then tumbled by 391.0% to -$92.7 million in 2022, then slumped by 300.5% to -$371.1 million in 2023.
  • Business Quant data shows HLN's Non Operating Interest Expenses at -$371.1 million in Q4 2023, -$155.2 million in Q2 2023, and -$116.2 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 -371.10 Mn
Jun 30, 2023 -155.17 Mn
May 3, 2023 -116.16 Mn
Dec 31, 2022 -92.66 Mn
Sep 20, 2022 -97.27 Mn
Dec 31, 2021 -18.87 Mn